Passage Bio Inc. (NASDAQ: PASG)
$0.95
+0.0288 ( +3.13% ) 1.4M
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.95
Previous close
$0.92
Volume
1.4M
Market cap
$58.63M
Day range
$0.87 - $1.12
52 week range
$0.58 - $1.79
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 15 | Jul 16, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 8-k | 8K-related | 13 | May 22, 2024 |
| 10-q | Quarterly Reports | 63 | May 14, 2024 |
| 8-k | 8K-related | 47 | May 14, 2024 |